[HTML][HTML] Chronic complications of venous thromboembolism

MP Winter, GH Schernthaner, IM Lang - Journal of Thrombosis and …, 2017‏ - Elsevier
Venous thromboembolism (VTE) is a common disease (~ 700 per 100 000) that is
associated with significant risk of recurrence, chronic complications, and substantial …

Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences

JR Schein, CM White, WW Nelson, J Kluger… - Thrombosis …, 2016‏ - Springer
Vitamin K antagonists (VKAs) are effective oral anticoagulants that are titrated to a narrow
therapeutic international normalized ratio (INR) range. We reviewed published literature …

Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis

YW Cheung, S Middeldorp, MH Prins… - Thrombosis and …, 2016‏ - thieme-connect.com
Post-thrombotic syndrome (PTS) is a common complication of deepvein thrombosis (DVT).
Poor quality treatment with vitamin K antagonists (VKA) is a risk factor for PTS. We …

Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences

A Bellesoeur, A Thomas-Schoemann, M Allard… - Critical reviews in …, 2018‏ - Elsevier
The use of anticoagulants in patients with cancer is challenging as several co-morbidities
modifying pharmacokinetic (PK) parameters and significant drug-drug interactions with …

Outcomes of patients with a mechanical heart valve and poor anticoagulation control on warfarin

I Johansson, AP Benz, T Kovalova… - Thrombosis and …, 2024‏ - thieme-connect.com
Background Patients with a mechanical heart valve (MHV) require oral anticoagulation. Poor
anticoagulation control is thought to be associated with adverse outcomes, but data are …

Extended treatment of venous thromboembolism: a systematic review and network meta-analysis

KL Wang, N van Es, C Cameron, LA Castellucci… - Heart, 2019‏ - heart.bmj.com
Objective To evaluate efficacy and safety of oral anticoagulant regimens and aspirin for
extended venous thromboembolism (VTE) treatment. Methods We searched MEDLINE …

International consensus statement on the peri‐operative management of direct oral anticoagulants in cardiac surgery

G Erdoes, B Martinez Lopez De Arroyabe… - …, 2018‏ - Wiley Online Library
Despite current recommendations on the management of severe peri‐operative bleeding,
there is no pragmatic guidance for the peri‐operative monitoring and management of …

Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism

CI Coleman, TJ Bunz… - Thrombosis and …, 2017‏ - thieme-connect.com
The efficacy and safety or rivaroxaban versus enoxaparin/vitamin K antagonist for treatment
and prevention recurrence of venous thromboembolism (VTE) was demonstrated in the …

Pros and cons of vitamin K antagonists and non–vitamin K antagonist oral anticoagulants

N Riva, W Ageno - Seminars in Thrombosis and Hemostasis, 2015‏ - thieme-connect.com
Anticoagulant treatment can be currently instituted with two different classes of drugs: the
vitamin K antagonists (VKAs) and the newer,“novel” or non–vitamin K antagonist oral …

Point-of-care coagulation monitoring: First clinical experience using a paper-based lateral flow diagnostic device

MA Hegener, H Li, D Han, AJ Steckl… - Biomedical …, 2017‏ - Springer
Vitamin K antagonists such as warfarin are the most widely used class of oral
anticoagulants. Due to a narrow therapeutic window, patients on warfarin require regular …